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Background: A UK Register of people with Multiple Sclerosis has been developed to address the need for an
increased knowledge-base about MS. The Register is being populated via: a web-based portal; NHS neurology
clinical systems; and administrative data sources. The data are de-identified and linked at the individual level. At the
outset, it was not known whether people with MS would wish to participate in the UK MS Register by personally
contributing their data to the Register via a web-based system. Therefore, the research aim of this work was to
build an internet-mounted recruitment and consenting technology for people with Multiple Sclerosis, and to assess
its feasibility as a questionnaire delivery platform to contribute data to the UK MS Register, by determining whether
the information provided could be used to describe a cohort of people with MS.
Methods: The web portal was developed using VB.net and JQuery with a Microsoft SQL 2008 database. UK adults
with MS can self-register and enter data about themselves by completing validated questionnaires. Descriptive
statistics were used to characterise the respondents.
Results: The web portal was launched in May 2011, and in first three months 7,279 individuals registered on the
portal. The ratio of men to women was 1:2.4 (n = 5,899), the mean self-reported age at first symptoms was 33.8 (SD
10.5) years, and at diagnosis 39.6 (SD 10.3) years (n = 4,401). The reported types of MS were: 15% primary
progressive, 63% relapsing-remitting, 8% secondary progressive, and 14% unknown (n = 5,400). These characteristics
are similar to those of the prevalent MS population. Employment rates, sickness/disability rates, ethnicity and
educational qualifications were compared with the general UK population. Information about the respondents’
experience of early symptoms and the process of diagnosis, plus living arrangements are also reported.
Conclusions: These initial findings from the MS Register portal demonstrate the feasibility of collecting data about
people with MS via a web platform, and show that sufficient information can be gathered to characterise a cohort
of people with MS. The innovative design of the UK MS register, bringing together three disparate sources of data,
is creating a rich resource for research into this condition.
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Multiple Sclerosis (MS) is a degenerative neurological dis-
order that is estimated to affect around 85,000 to 100,000
people in the UK [1,2]. Programmes for treating and man-
aging MS should be underpinned by robust data, but it has
been recognised that there is a significant lack of reliable,
evidence-based information to inform service delivery and
to generate important health service research on MS in the
UK [3]. This may be due to a number of factors such as
the prolonged disease course, evolving over several decades
[4], and difficulties or delays in diagnosis, as people may
present with a wide variety of symptoms [5]. To date, there
is no central repository for MS data in the UK. There are a
number of different database systems in MS treatment
centres, but no agreed data model and no network and
policy infrastructure for sharing data between NHS settings
[3,6]. In response to this, the MS Society of Great Britain
and Northern Ireland [2] commissioned the development
of the UK MS Register.
The aim of the work was to build a working prototype
MS Register, for use in 5 centres across the UK, capable of
being scaled to a national deployment. There are two clin-
ical sites in England, one in Wales, one in Scotland and one
in Northern Ireland. The Register has been designed to cap-
ture three main categories of data and to be able to an-
onymously link these data at the individual level whilst
retaining privacy. Data are collected directly from people
with MS via a purpose-built web portal, from patient-
management systems operating in NHS neurology clinics,
and from sources of routine administrative data (such as
primary care and hospital data). Numerous datasets may be
included in each of the three categories. There are other na-
tional registers for people with MS such as in Denmark,
Norway, Sweden, Italy, Germany and North America [7].
However, these collect data from only one or two of these
categories, though this may include multiple datasets. By
uniting datasets from three disparate categories the UK MS
Register model is innovative in its design and provides new
opportunities for studying MS via linked data. The Register
is operating initially a prevalence-based register, but as we
continue to collect data, with regular updates from the dif-
ferent sources, we will be able to estimate incidence. Our
aim is to create a UK population Register of people with
MS, with as complete coverage as can be obtained whilst
acknowledging that participation is voluntary. This register
model could also be applied in other disease conditions.
Research aim
At the outset of this work it was not known whether people
with MS would wish to participate in the UK MS Register
by personally contributing their data to the Register via a
web-based system. Therefore, the objective of the work
described here was to build an internet-mounted recruit-
ment and consenting technology for people with MS, andto assess its feasibility as a questionnaire delivery platform
by determining whether the information provided could be
used to describe a cohort of people with MS. In order to do
this, we provide a description of the development of the
portal and the self-reported characteristics of its first cohort
of people with MS.
Methods
Research ethics and governance
The UK MS Register study was granted ethical approval by
the South West – Central Bristol Research Ethics Commit-
tee (11/SW/0160) under the category of a research data-
base [8]. The Register has been based on the proven
technologies and robust Information Governance arrange-
ments in place in the Secure Anonymised Information
Linkage (SAIL) system developed by the Health Informa-
tion Research Unit (HIRU) [9,10]. HIRU aims to realise the
potential of electronically held, person based, routinely col-
lected information and to bring together expertise in health
informatics to support and conduct research. The SAIL
databank holds multiple, disparate person-level datasets
drawn from operational and national systems, and over 2
billion anonymous records have been loaded to date. Novel
anonymisation, encryption and linkage processes have been
developed to manage and link datasets securely, so that the
SAIL databank is an extremely successful method of acces-
sing linked data from individuals while preserving their
anonymity. Under the ethical approval that has been
obtained, data collected via the portal, the neurology clinics
and routine administrative sources can be anonymously
linked using the SAIL methodologies provided that agree-
ment to the portal terms of service (via the portal) and
written informed participant consent (at the clinics) have
been obtained. The consent process at the neurology
clinics is for the provision of identifiable data to the Regis-
ter, so that the identifiable details can used to enable record
linkage. Datasets are linked at the individual level using
first name, surname, date of birth, gender and postcode as
the matching variables, and then a unique anonymous
identifier is assigned to each individual in the dataset to act
as a linking field across datasets. This, together with a de-
duplication process, ensures that each person is included
on the Register only once. The working UK MS Register
contains only anonymous data but facilities are in place to
re-contact participants to take part in further research.
Development and implementation of the web portal
Although the development of the portal is embedded in
the SAIL system, it is not specific to SAIL. It uses com-
monly used toolsets and other systems could equally
form the basis of such a portal, either as part of a regis-
ter or standalone. The portal was developed in Visual
Studio 2010, deployed on Microsoft IIS (Internet Infor-
mation Services) and the data are stored securely in
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the portal are a mixture of HTML and JQuery which is
a Javascript library. This mix of technology was used to
allow a deeper level of interaction and feedback to the portal
users. There are three routes by which people with MS can
access this questionnaire-delivery platform: via the standa-
lone register web portal [11], through the MS Society web-
site (available to members of the Society [2], or via a
purpose-built web application on Facebook [12]. These entry
options are designed to boost recruitment and are ultimately
all routed to the questionnaire-delivery platform. People
who use the main Register web portal are directly authenti-
cated via the portal. Users select their own usernames, which
must be unique, and passwords are stored as salted hash ele-
ments within the database, providing a high level of security.
The second method makes use of an authentication token
from the UK MS Society website. In this case, no identifiable
details are transferred between the MS Society and the
Register portal, just the token. This allows members of the
Society to join the Register without having to remember an
additional user name and password. Once logged in and
registered, an XML message is returned to the MS Society
member. This is displayed to them as an interactive element
that allows them to return to the Register at will whilst
logged in to the MS Society site. The final method of au-
thentication is via the Facebook social networking site. Web
developers within Swansea University created a Facebook
application via the published guidelines [13]. Again, only au-
thentication information is provided and no personal or clin-
ical information is shared with Facebook. Users must be
logged into Facebook and agree to install the Register appli-
cation. They then access the Register from the link that the
application installs in their Facebook profile.
Following the development process a demonstration portal
was implemented for usability testing and improvement.
Feedback on its utility was obtained from people with MS
and key stakeholders, including clinicians and representa-
tives of the MS Society before the portal was formally
launched to the public. The work on usability testing is the
subject of another article which is in preparation. The launch
of the portal was marked by a nationwide advertising cam-
paign by the MS Society and mailings to MS Society mem-
bers, radio and TV broadcasts and national newspaper
articles [14,15]. People (over 18 yrs) with a diagnosis of MS
and living anywhere in the UK are eligible to register on the
web portal. Participants must have a functional email ad-
dress and to be able to agree to the terms of service.
Data collection and analysis
The web portal collects demographic data from people
with MS and hosts a number of validated questionnaires.
These instruments were chosen following a literature re-
view and discussions with key stakeholders, including neur-
ology clinicians, people with MS, researchers and the MSSociety. They include the Hospital Anxiety and Depression
scale [16], the MS Disease Impact Scale-29 [17], and the
EQ-5D [18], covering a range of topics such as: MS and
mental well-being; MS and quality of life; MS and lifestyle;
and medication records. The questionnaire entitled ‘You,
your MS and lifestyle’ collects baseline information about
MS including: date of diagnosis of MS, type of MS and age
at onset, plus information on education, employment and
living arrangements for people with MS. Recruitment to
the web portal is on-going, and people who register are
sent an email every 3 months inviting them to return to
the portal and update their questionnaires to build up a
longitudinal data source.
The responses to ‘You, your MS and lifestyle’ (obtained
between May and July 2011) were used as the sample for
data analysis in this work. They were collated with the
basic demographic characteristics (such as age and gen-
der) required to register on the portal in order to be able
to explore various factors about living with MS. Following
quality assurance, the resulting anonymised dataset was
analysed (in SPSS v.16) using descriptive statistics to show
the sort of information that can be collected and to pro-
vide a general profile of the first cohort in the UK MS
Register. The characteristics of the respondents were com-
pared with published reports on the prevalent MS popula-
tion, and employment profiles, ethnic composition, and
highest educational attainments of people with MS were
compared with the general UK population [19-21].
Results
The web portal was successfully launched in May 2011
and within three months 7,279 individuals had enrolled
on the MS Register via the web portal. Taking into ac-
count that there are estimated to be between 85,000 and
100,000 people with MS in the UK [1,2], this represents
an approximately 8% sample of the prevalent MS popula-
tion. Of these respondents, 97% entered directly via the
stand-alone website, 2% registered by way of the UK MS
Society website, and 1% registered through the use of the
Facebook application. Once registered, people can choose
whether to provide additional information via completion
of the questionnaires. This work relates to ‘You, your MS
and lifestyle’ and majority went on to complete this ques-
tionnaire. As this questionnaire contains disparate ques-
tions, and is not an assessment tool that produces an
overall score, it is not necessary for it to be completed it
in its entirety in order to be able to use the data. The rate
of responses ranged from 61% (UK country of origin) to
82% (types of first symptoms) and numbers of responses
are shown in the text with the relevant results.
Demographics
There were 3,290 respondents who stated they lived in
England, 619 in Scotland, 342 in Wales and 177 were of
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respondents was 1: 2.4 (n= 5,899) and there was a broad
age range among the respondents at time of enrolment:
18 to 95 years, with a mean age of 50.8 (SD 11.4) years
and a median of 50.0 years. The ethnic composition of the
group (n= 5,780) was largely White British (93.8%) with a
variety of other ethnicities making up the remainder.
MS and diagnosis
MS is classified into different types depending on the char-
acteristics of the disease course. The majority of patients
are initially diagnosed with relapsing-remitting MS (RRMS),
but this may change over time [2]. Of the respondents that
provided their information on this (n=5,400), 15% reported
having primary progressive MS (PPMS), 63% stated that
they had RRMS, and 8% had secondary progressive MS
(SPMS). The remaining 14% did not know which type of
MS they had. The distribution of reported type of MS by
gender is shown in Figure 1. It can be seen that relatively
greater proportions of men report that they have a progres-
sive type and relatively greater proportions of women report
having RRMS. A first-degree family member (parent, sibling
or child) with MS was reported by 8.5% of the respondents.
Of these 4% had a parent who had MS, 4% had a sibling
with MS, and 0.5% stated that they had a child who devel-
oped MS.
The mean age at which the respondents recalled first ex-
periencing symptoms of MS was 34.0 (SD 10.5) years
(n=4,918), and the mean age at which their diagnosis was
confirmed was 39.4 (SD 10.1) (n=4,883). The mean time
since their diagnosis was confirmed was 11.4 (SD 8.9) years
with a range of 0 to 63 years. This indicates that our sample
contains a breadth of respondents spanning recently-
diagnosed and long-term. Although there is no definitive
list of early MS symptoms, the ones experienced by the
respondents (n=5,969) were among the most common: [2]Figure 1 The distribution of types of MS by gender. People with
MS provided information on the type of MS they have been
diagnosed with. The proportions are indicated here, grouped by
gender.67% had difficulty walking, 65% experienced numbness,
and 59% had vision problems. These symptoms were some-
times present in combinations: for example, 25% of respon-
dents reported experiencing all three effects and only 2%
reported that they did not experience any of these symp-
toms. A Venn diagram showing the proportions of people
with MS experiencing the various combinations of these
symptoms is shown in Figure 2.
People with MS reported different experiences in the
process of their diagnosis. However, in accordance with
the McDonald criteria [22,23], the majority received an
MRI scan (79%) and in 29% of cases this was used in con-
junction with CSF (lumbar puncture) and clinical findings.
Less than 4% (3.7%) did not recall receiving either of these
and stated that they were diagnosed from clinical findings
alone. Most people (79%) were given the diagnosis of MS
by a consultant neurologist, 19% by a consultant physician
and less than 2% by a general practitioner (n= 5,736).
Education and employment
The respondents were asked about their highest educa-
tional achievements. Among the 5,819 respondents, the
largest single qualification was an occupational certifi-
cate or diploma (34%), a third (33%) attained a university
bachelor or postgraduate degree, just over a quarter
(26%) were educated to secondary school level and only
0.2% left school after primary school. The remainder
(7%) indicated that they had miscellaneous qualifications
or overseas education (Figure 3).
The people with MS were asked about their usual occu-
pation and the resulting profile (n = 5,046) was compared
with the actual employment profile of the general UK
population using the official labour market categories for
2010–2011 (Table 1) [19]. It can be seen that in some cat-
egories the respondents usual occupations are similar to
the actual figures for the UK, and in others, they differ. It
should be noted that this compares usual with actual
occupations, and our sample consists of approximately
30% men and 70% women, whereas the UK workforce is
approximately 54% men and 46% women [19].
The responses on actual employment status showed that
36.9% of the sample were in employment, which equates
to 41.9% of the people of working age, and of these, the
majority were in part-time work (88%). By comparison,
76.9% of the general UK population (aged 16 to 64 years)
are economically active [19]. Almost a third of the respon-
dents (29.8%) reported that they were sick/disabled, equat-
ing to 32.7% of working age, with the majority reporting
that they are permanently (rather than temporarily) sick/
disabled (91%). This is higher than the 24.5% of the
working-age UK population recorded as being sick/dis-
abled [19]. The differences in the employment and sick/
disabled rates between people with MS and the general UK
population show the impact of MS on the UK workforce.
Figure 2 Initial symptoms experienced by people with MS. People with MS were asked to indicate whether they experienced numbness,
difficulty walking or problems with their vision, or combinations of these symptoms, among their initial symptoms of MS.
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had retired, and this equates to 86% of the over 65 s age
group. The remainder of the respondents were engaged in
activities such as education, home-making or voluntary
work, or they gave their status as unemployed.
The distributions of the types of MS among the people
who were employed were compared to those of people
who were sick/disabled. Among the employed respon-
dents 20.3% reported having PPMS, 40.4% RRMS, 10.0%
SPMS and 29.3% did not know which type of MS they
had. This indicates that, as might be expected, higher
proportions of people with RRMS are in work compared
to the progressive types of MS. Among the sick/disabled
respondents there were 27.6% with PPMS, 20.9% with
RRMS, 31.9% with SPMS and 19.6% did not know their
type of MS. This is the converse, as it shows that greaterFigure 3 Highest educational attainment reported by people with MS
educational attainments.proportions of people with a progressive type of MS are
sick/disabled compared to people with RRMS.
The employment rate among the respondents who
reported that they were working (<=64 for men and<=59
for women) was assessed against the length of time since
their MS was diagnosed (in 5 year bands). As would be
expected, this showed that the proportions of people in
employment declines with increasing time since diagnosis
(Figure 4). For example, over 40% of the people who are
working have a recent diagnosis (0 to 4 years), and only
approximately 2% of the people who are working have
been diagnosed for 25 years or more. A similar analysis
was conducted to assess the rate of sick/disabled respon-
dents of working age and, as would be expected, this
showed a steady increase in cumulative proportions by
time since diagnosis (Figure 5).. People with MS provided information about their highest
Table 1 Usual employment types among people with MS
Employment type Respondents % UK %
Administrative & secretarial 22.8 10.7
Associate professional & technical 10.4 14.7
Caring, leisure & other personal service 3.9 8.8
Elementary occupations 1.9 11.3
Managerial, director or senior official 15.6 15.6
Process plant/machine operatives 1.2 6.6
Professional 30.5 14.1
Sales & customer service 7.2 7.4
Skilled/trade 6.4 10.3
People with MS provided information on their usual type of occupation. This is
compared with the actual employment profile for the UK population (2010–
2011). These profiles are discussed in the text.
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There were a wide range of living arrangements among
the respondents (n= 5,604). The most frequently reported
household settings for the people with MS were as: an
adult couple not on a pension and with (non-dependent
and/or dependent) children (25%); an adult couple on a
pension with no dependent children (23%); an adult
couple not on a pension and with no children (16%); and
a single pensioner (15%). Some respondents in adult cou-
ples reported that they live in households with other rela-
tives or unrelated adults (8%). Altogether there were 31%
with dependent children and 3.3% were single parents
with dependent children.
Discussion
Main findings of this study
The main findings of this study are two-fold. Firstly, we
have shown that it is possible to collect information
from thousands of people with MS via a web-based
questionnaire delivery platform. Secondly, sufficient in-
formation can be gathered to characterise a cohort of
people with MS to feed into the Register. This providesFigure 4 Employment rates by time since diagnosis. Proportional rates
against the duration of the MS diagnosis in 5 year bands.new information about the lives of people with MS in
the UK from their own perspective. This is encouraging
as it supports the continuance of collecting information
for the UK MS Register via this route, and this design
could be used to set up a similar portal to collect data
from people with other conditions.
What is already known on this topic
There are numerous research programmes seeking to
understand the possible causes of MS and to develop
drug therapies to manage the condition. However, it is
acknowledged that there is a great shortage of informa-
tion to guide service delivery and research about MS [3],
and this led the MS Society to commission a UK MS
Register. It is estimated that (in 2008) there were ap-
proximately 85,000 people with MS in the UK, with a
mean age of onset of 32.5 years, and gender proportions
of 1:2 to 1:3 male to female [1,2].
Data validity
Through the analyses we have conducted we have shown
that we have a broad sample of ages and MS durations
and that our respondents are reasonably representative
of the prevalent MS population. The gender proportions,
mean age at onset, proportions of MS types, and the dis-
tribution of types of MS by gender in our findings are
similar to other reports [1,2,24]. We cannot yet estimate
prevalence from this initial, unlinked dataset, but we will
be able to do this in the near future when we are able to
link portal responses with other sources of data.
We compared various features of the sample with the
general UK population. In the 2001 census, approxi-
mately 85.7% of the UK population reported that they
were White British, and 91.4% White British/Irish/Other,
with the remainder being made up of various ethnic
groups [20]. There may be minor changes in the UK
population over time since the census was taken but the
higher proportion observed in our sample (93.8%) is notof employment for people with MS of working age were assessed
Figure 5 Rates of sickness/disability status by time since diagnosis. This shows the cumulative percentage of people with MS of working
age reporting their status as sick/disabled by length of diagnosis (in 5 year bands).
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populations [25]. The respondents were similar to the UK
population in highest educational attainment. The UK
Labour Force survey for 2011 showed that 31% held a first
degree or a higher degree, and 29.3% did not progress be-
yond secondary education [19]. In our sample 33% held a
first degree or a higher degree, and 26.2% were educated
to secondary level. People with MS were asked about their
usual occupations and these were compared with the ac-
tual occupations of the UK workforce, and although there
were some similarities, some obvious differences were
seen in the occupation profiles (Table 1). The full reasons
for these differences are not known at this stage. However,
it is worth noting that the comparison was of usual occu-
pations with actual occupations, and it is possible that dif-
ferences would also be noted if the usual and actual
occupations of the general UK population were compared,
as people may work in jobs outside their usual occupation
type. Only approximately 42% of our potential MS work-
force were in employment and it is possible that the
observed profile also reflects the types of occupation that
people with MS are able to continue working in. Also, the
gender proportions of our sample are different to those of
the UK workforce, and this may influence the distribution
of occupation types with some types of work being more
common to one gender or the other. Although further
work needs to be carried out to understand the occupa-
tion profiles, the analyses on employment status, namely,
the distributions of types of MS among people who are
working and among people who report that they are sick/
disabled, and the trends in employment rates and sick-
ness/disability rates over time are in keeping with what
would be expected in a degenerative condition like MS.
What this study adds
In collecting data from clinical settings, administrative
datasets and directly from people with MS, the UK MSRegister has a broader data model than other national MS
Registers which use only one or two categories of data
[7,26]. This model could be applied to other disease Regis-
ters. The web portal provides a flexible platform for the de-
livery of a range of questionnaires, providing all people
with MS in the UK an opportunity to contribute their data,
which is of potentially great value to service planning and
research. This study has provided information from people
with MS on their demographics, the process of their diag-
nosis and the type of MS they believe they have, and on
their education, employment and living arrangements.
Future work
Future work will include analysis of the responses to
other questionnaires delivered via the platform, to create
a fuller picture of living with MS. We will also link and
compare the self-reported information with clinical and
administrative data to estimate disease prevalence and to
carry out further validation. Since MS can be difficult
and lengthy to diagnose, we are developing a case ascer-
tainment algorithm to use against routine data (such as
primary and secondary care records). This will help us
to study the anonymous routine data to profile the
group of people with MS who are not on the Register
and thus enable us to target further recruitment activ-
ities. We are engaging in a series of marketing activities
to promote the Register and to encourage further par-
ticipation, and through these methods we are seeking to
ensure that the Register is inclusive and representative
of the UK MS population. Furthermore, a programme of
qualitative research is underway to engage with people
with MS to improve our understanding of their needs in
contributing to the Register. For example, we are seeking
to understand their internet preferences, such as their
reasons for choosing a particular portal entry route, so
that we can optimise enrolment on the Register [27]. In
future, the Register data will be made accessible for
Ford et al. BMC Medical Informatics and Decision Making 2012, 12:73 Page 8 of 8
http://www.biomedcentral.com/1472-6947/12/73analysis, subject to regulatory and governance require-
ments. The final operating model for these arrangements
is yet to be determined.
Limitations of this study
The information used in this study was self-reported and
the respondents are not necessarily a fully representative
sample of people with MS in the UK. Ascertainment is
commonly assumed to be skewed when using web-based
methods, as the technology may pose a barrier to the
elderly, disadvantaged, technically inexperienced or cog-
nitively impaired [28,29]. Response bias in portal data
will be addressable using the linkable data from clinical
sites and routine sources, as the Register continues to
build up an increasingly detailed picture of MS in the
UK and to become a rich information resource.
Conclusions
The initial findings from the MS Register portal demon-
strate the feasibility of collecting data about people with
MS via a web-based questionnaire delivery platform, and
show that sufficient information can be gathered to
characterise a cohort of people with MS. The innovative
design of the UK MS register, bringing together three
disparate sources of data, is creating a rich resource for
research into this condition.
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